Hybrid ligand directed to activation of cytotoxic effector T lymphocytes and target associated antigen

• 1. 用α胸腺肽和抗细胞毒性T淋巴细胞相关抗原4(CTLA4)的抗体的组合治疗黑素瘤 [P] . 中国专利： CN101896190A . 2010-11-24
• 2. 一种高效的细胞毒性T淋巴细胞激活增殖制备方法 [P] . 中国专利： CN112175903A . 2021-01-05
• 3. IDENTIFICATION OF ANTIGENIC PEPTIDES BY CYTOTOXIC T LYMPHOCYTES ACTIVATED BY DENDRITIC CELL HYBRIDS [P] . 欧洲知识产权局专利： EP1263928B1 . 2007-09-26

  机译： 树突状细胞杂种活化的细胞毒性T淋巴细胞鉴定抗原肽

• 4. COMPOSITIONS CAUSING SPECIFIC RESPONSE OF CYTOTOXIC T-LYMPHOCYTES, INCLUDING LYMPH-ABLATIVE COMPOUND AND MOLECULE WHICH CONTAINS ANTIGEN SEQUENCES AND IS TARGETED AT SPECIALISED ANTIGEN-PRESENTING CELLS [P] . 俄罗斯专利： RU2448729C2 . 2012-04-27

  机译： 引起细胞毒性T淋巴细胞特异性反应的成分，包括具有抗原序列的淋巴结复合物和分子，并靶向于特定的抗原呈递细胞

• 5. METHOD FOR PRODUCTION OF IN VITRO POPULATIONS OF ACTIVATED ANTIGENSPECIFIC ANTITUMOR-TUMOR CYTOTOXIC T-LYMPHOCYTES SPECIFIC TO TUMOR-ASSOCIATED ANTIGEN EPITOPES [P] . 俄罗斯专利： RU2619186C1 . 2017-05-12

  机译： 肿瘤相关抗原表位特异性活性抗肿瘤抗肿瘤T细胞的体外生产方法

• 1. Suppressive effects of antigens on the activity of specific activated lymphocytes: A test to define the specificity of activated lymphocytes [J] . HU Jun, PAN Sheng-jun, CAI Zhen-jie, 中国人民解放军军医大学学报（英文版） . 2006,第003期
• 2. SART1 Gene Encoding Squamous Cell Carcinoma Antigen Recognized by Cytotoxic T Lymphocytes [C] . Kyogo Itoh, Shigeki Shichijo, Yoshiko Inoue, Keio International Symposium for Life Sciences and Medicine . 2000
• 3. Cytotoxic effects associated with targeting the subcellular distribution of the bioreductive enzyme, DT -diaphorase, and mitomycin C activation. [D] . Seow, Helen Antoinette. 2002
• 4. Neoplasia: Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia [O] . Concetta Quintarelli, Gianpietro Dotti, Biagio De Angelis, -1
• 5. B-Lymphocytes Activated by CD40 Ligand Induce an Antigen-Specific Anti-Tumour Immune Response by Direct and Indirect Activation of CD8+ T-cells [O] . D. S. Ritchie, J. Yang, I. F. Hermans, 2004

• 1. Procedure for preparing peptide-major histocompatibility complex tetramers for direct quantification of antigen-specific cytotoxic T lymphocytes [J] . Xian-Hui He ,Li-Hui Xu ,Yi Liu . 世界胃肠病学杂志：英文版 . 2005,第27期
• 2. Glypican-3-specific cytotoxic T lymphocytes induced by human leucocyte antigen-A*0201-restricted peptide effectively kill hepatocellular carcinoma cells in vitro [J] . Jiang-Zheng Zeng ,Yu Liu ,Fen Huang . 亚太热带医药杂志：英文版 . 2017,第11期
• 3. In-vitro activation of cytotoxic T lymphocytes by fusion of mouse hepatocellular carcinoma cells and lymphotactin gene-modified dendritic cells [J] . Xi-Ling Sheng ,Hao Zhang . 世界胃肠病学杂志：英文版 . 2007,第44期
• 4. MUC1 Antigen-Specific CD8 T Lymphocytes Targeting MCF7 and MDA-MB-231 Human Breast Adenocarcinoma Cell Lines [J] . Panagiotis Parsonidis ,Dimitrios-Athanasios Ntanovasilis ,Ioannis Papasotiriou . 癌症治疗（英文） . 2019,第7期
• 5. 细胞毒性T淋巴细胞相关抗原4基因多态性与肝癌的易感性研究 [C] . Cui Wei-li ,崔伟丽 ,赵文革 . 中国医师协会中西医结合医师分会肝病专业委员会、广东省药学会中医肝病用药专家委员会、广东省保健协会肝病专业委员会2016年学术会议 . 2016
• 6. 细胞毒性T淋巴细胞相关抗原-4单克隆抗体在荷人T细胞淋巴瘤Jurkat细胞裸鼠中作用的实验研究 [A] . 徐振华 . 2010